Abbott Structural Heart Device Registry
Launched by ABBOTT MEDICAL DEVICES · Sep 9, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The Abbott Structural Heart Device Registry is a study aimed at evaluating the safety and effectiveness of certain heart devices made by Abbott. These devices are used to treat various heart conditions, such as holes in the heart (like atrial septal defect and ventricular septal defect) and valve problems. The study involves collecting information from hospitals about how these devices are performing in real-life situations after they have already been approved for use. This data will help ensure that the devices continue to meet safety standards set by health authorities.
To be eligible for this study, participants should be scheduled to receive one of the Abbott heart devices or have already had one implanted recently. They must also agree to follow up with their healthcare providers as recommended. Participants will be asked to give their consent to join the study, and if they meet the criteria, they can contribute valuable information that helps improve heart care for everyone. The study is currently looking for participants of all ages and genders.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Subject is expected to undergo an implant attempt using one or more Abbott Structural Heart devices covered in this Registry or has previously undergone an implant attempt within the timeframes specified in the device-specific appendices.
- • 2. Subject is willing and able to comply with the site's standard of care follow-up schedule.
- • 3. Subject is willing to provide appropriate informed consent for Registry participation. For deceased subjects enrolled retrospectively, local regulations and EC/IRB recommendations regarding consent and the protection of personal data must be followed.
- Exclusion Criteria:
- • 1. Subject is participating in another clinical study that would affect the results of this Registry.
About Abbott Medical Devices
Abbott Medical Devices is a leading global healthcare company dedicated to advancing medical technology through innovative research and development. With a robust portfolio of diagnostic, therapeutic, and monitoring solutions, Abbott is committed to improving patient outcomes and enhancing the quality of care across various medical fields. The company places a strong emphasis on clinical trials to validate the safety and efficacy of its products, ensuring compliance with regulatory standards and fostering collaboration with healthcare professionals. By leveraging cutting-edge science and technology, Abbott Medical Devices aims to address pressing health challenges and deliver transformative solutions that empower patients and healthcare providers alike.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Pessac, , France
London, , United Kingdom
London, , United Kingdom
Jena, , Germany
Pisa, Tuscany, Italy
Le Plessis Robinson, , France
Madrid, , Spain
Sevilla, , Spain
Berlin, , Germany
Munchen, Bavaria, Germany
Bad Rothenfelde, , Germany
San Donato Milanese, Lombardy, Italy
Rennes, Brittan, France
Braunschweig, L Saxon, Germany
Patients applied
Trial Officials
Ryan Palmer
Study Director
Abbott
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported